Lou Tartaglia
InvestorManaging Partner at Cure Ventures · Board director at Crosslink Therapeutics
Greater Boston
Find your path to Lou
451 people in our graph share verified history with Lou — schools, employers, funds. One of them is your warm intro.
Glen AndersonunlockedLou: together at University of California, Berkeley (1988–1990)
Lou: together at University of California, Berkeley
×10Lou: together at Third Rock Ventures
About
Managing Partner and Co-Founder with over 30 years in biotech and venture capital. Previously led 5AM Ventures' company formation initiative, was a Partner at Third Rock Ventures, and was the first employee of Millennium Pharmaceuticals.
Contact· published on Lou's own website
Board director at Crosslink Therapeutics
Intro paths
→
In turn, Lou can intro founders to Crosslink Therapeutics's investors below.
Crosslink Therapeutics's investors · 1
Experience
- Cure VenturesManaging Partner and Co-Foundercurrent2021 — present
- 5AM VenturesVenture Partner2018 — 2020Greater Boston
- 5AM VenturesHead of 4:592016 — 2018Greater Boston
- Solstice BiologicsCEO2014 — 2015San Diego/Boston
- Third Rock VenturesPartner2007 — 2014
- Gene LogicGeneral Manager2004 — 2007
- Millennium PharmaceuticalsVP Metabolic Diseases1993 — 2004
- GenentechPostdoc1990 — 1993
Skills & more
Biotechnology93Lifesciences36
From Lou's professional profile.
Deals · 1
Crosslink TherapeuticsBoard seat
via Cure Ventures · filed May 2025 · $8M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Ablexis
Sources: SEC Form D filings · curated public sources.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Frequently asked questions
- Who is Lou Tartaglia?
- Managing Partner and Co-Founder with over 30 years in biotech and venture capital. Previously led 5AM Ventures' company formation initiative, was a Partner at Third Rock Ventures, and was the first employee of Millennium Pharmaceuticals.
- Where does Lou Tartaglia work?
- Lou Tartaglia is Managing Partner at Cure Ventures and Board director at Crosslink Therapeutics.
- What boards does Lou Tartaglia sit on?
- Lou Tartaglia holds tracked board seats at Crosslink Therapeutics.
- What companies has Lou Tartaglia invested in?
- Investments tracked here include Ablexis.
- Where did Lou Tartaglia go to school?
- Lou Tartaglia studied at University of California, Berkeley (Doctor of Philosophy (Ph.D.), Biochemistry); University at Albany (Bachelor of Science (B.S.), Chemistry).
Founder mafias
Third Rock Ventures mafia23
Also came through, then founded or led a company.
Christoph LengauerPartnerFounded Celsius Therapeutics +3Reid HuberPartnerFounded MOMA Therapeutics +2Alexis BorisyPartnerFounded Foundation Medicine +2Steve PaulVenture PartnerFounded Voyager Therapeutics, Inc. +1Philip ReillyVenture PartnerFounded Luna Genetics +1Uday KumarEntrepreneur-in-ResidenceFounded Element Science +1
+ 16 more
University at Albany mafia19
Also came through, then founded or led a company.
Dave JohnsonPhDFounded Dash BioBruceDoctor of Philosophy - PhDFounded Predxbio +2Sal SferlazzaBachelor of ScienceFounded Boostlingo +1Guy DiPierroFounded Chrono Therapeutics +1Gabor ForgacsPostdoctoral FellowFounded Modern meadow +1Doug PerlsonBachelor of Arts - BAFounded Targetspot
+ 12 more
Cure Ventures mafia3
Also came through, then founded or led a company.
Same school
Also attended University of California, Berkeley2,000
Steve WozniakCo-founder of AppleAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksAbraham BachrachCo-founder & CTO of SkydioTrevor OelschigInvestment Team at General CatalystAnthony LinHead of Intel Capital, Corporate Vice President at Intel Capital
+ 1,994 more
Also attended University at Albany124
Dave JohnsonCo-founder & CEO of Dash BioMatthew AlfieriPartner at Centana Growth PartnersAngela AsencioManager, Therapeutics Team at Deerfield Management CompanyDaniel GlassManaging Director, Global Market Research at Deerfield Management CompanyJonathan IslerPartner and Chief Financial Officer, Funds at Deerfield Management CompanyChristine MurphyInvestor at TRANSFORMATION CAPITAL
+ 118 more
Shared employers
Also worked at Solstice Biologics1
Also worked at Third Rock Ventures90
Lisa PurcellInvestor at Third Rock VenturesPaul MeloneInvestor at Third Rock VenturesLee VeneziaInvestor at Third Rock VenturesKevin MunnellyInvestor at Third Rock VenturesAmanda ChanInvestor at Third Rock VenturesJigar RaythathaInvestor at Third Rock Ventures
+ 84 more
Also worked at Gene Logic3
Also worked at Millennium Pharmaceuticals50
David SchenkeinInvestor at GV (Google Ventures)Kevin MunnellyInvestor at Third Rock VenturesJohn KeiltyVenture Partner at Third Rock VenturesKevin GillisPartner and Chief Operating Officer at Third Rock VenturesRobert TepperPartner and co-founder of Third Rock VenturesStuart HwangVenture Partner at Remiges Ventures, Inc.
+ 44 more